Sam Agrawal

A phase 2 trial of the FLT 3 inhibitor lestaurtinib ( CEP 701 ) as first-line treatment for older patients with acute myeloid leukemia not considered fit for intensive chemotherapy

M. Levis, D. Small, R. Chopra, 2006 .

An unusual presentation of acute myeloid leukaemia with pericardial and pleural effusions due to granulocytic sarcoma.

J. Mehta, P. Mahendra, R. Powles, 1993, Leukemia & lymphoma.